<?xml version="1.0" encoding="utf-8"?>
<html madcap:lastblockdepth="4" madcap:lastheight="878" madcap:lastwidth="701" xmlns:madcap="http://www.madcapsoftware.com/Schemas/MadCap.xsd">
 <head>
 </head>
 <body>
  <h1>
   LifeCell Corporation
  </h1>
  <div style="display: none;">
   <table cellspacing="1" class="TableStyle-dnb_tablestyle_1" style="mc-table-style: url('../Resources/TableStyles/dnb_tablestyle_1.css');">
    <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
    </col>
    <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
    </col>
    <col class="TableStyle-dnb_tablestyle_1-Column-Column1">
    </col>
    <thead>
     <tr class="TableStyle-dnb_tablestyle_1-Head-Header1">
      <th class="TableStyle-dnb_tablestyle_1-HeadE-Column1-Header1">
       DUNS
      </th>
      <th class="TableStyle-dnb_tablestyle_1-HeadE-Column1-Header1">
       Hoovers ID
      </th>
      <th class="TableStyle-dnb_tablestyle_1-HeadD-Column1-Header1">
       Tier
      </th>
     </tr>
    </thead>
    <tbody>
     <tr class="TableStyle-dnb_tablestyle_1-Body-Body1">
      <td class="TableStyle-dnb_tablestyle_1-BodyB-Column1-Body1" style="text-align: center;">
       157224205
      </td>
      <td class="TableStyle-dnb_tablestyle_1-BodyB-Column1-Body1" style="text-align: center;">
       45891
      </td>
      <td class="TableStyle-dnb_tablestyle_1-BodyA-Column1-Body1" style="text-align: center;">
       2
      </td>
     </tr>
    </tbody>
   </table></div><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Synopsis.flsnp" /><p>
   LifeCell puts new life into the tissue graft market. The company makes soft tissue material for surgeries ranging from complex hernia repair to breast reconstruction. Products include Strattice Reconstructive Tissue Matrix, AlloDerm Regenerative Tissue Matrix, and an injectable form of Alloderm called Cymetra MAT. Its SPY Elite intraoperative system assists surgeons in visualizing tissue perfusion (flow of blood into tissue) in plastic, reconstructive, micro, gastrointestinal, and cardiovascular surgery procedures. Holding company
   <company id="163564">
    Acelity
   </company>
   sold LifeCell to
   <company id="12311">
    Allergan
   </company>
   for $2.9 billion in early 2017.
  </p>
  <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Operations.flsnp" />
  <p>
   LifeCell makes a variety of tissue repair products used in reconstructive, orthopedic, and urogynecologic surgeries.
  </p>
  <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Geographic Reach.flsnp" />
  <p>
   LifeCell has offices in Branchburg and Bridgewater, both in New Jersey.
  </p>
  <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Sales and Marketing.flsnp" />
  <p>
   The company markets and sells its portfolio of products through distributors in the US and international markets. Its products are marketed for specific applications and procedures, including grafting, plastic surgery, and reconstruction in the areas of head and neck and ear, nose, and throat (ENT).
  </p>
  <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Strategy.flsnp" />
  <p>
   Research leading to new product launches is an important part of LifeCell's long-term growth strategy. The company has about a dozen major research initiatives underway at any given time. LifeCell's research initiatives are funded both by product sales and by grants from outside organizations including the
   <company id="100358">
    National Institutes of Health
   </company>
   .
  </p>
  <p>
   More recent product launches include AlloDerm RTM Ready to Use in 2012 and the REVOLVE system for fat transfer in 2013. In 2014 it purchased the fat grafting tool adipose Tissue Injector from TauTona Group.
  </p>
  <p>
   In early 2017,
   <company id="163564">
    Acelity
   </company>
   sold LifeCell to
   <company id="12311">
    Allergan
   </company>
   for $2.9 billion. LifeCell joined Allergan's existing portfolio of medical aesthetics and breast implants.
  </p>
  <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /><MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/H2 Company Background.flsnp" />
  <p>
   Former parent
   <company id="13908">
    Kinetic Concepts
   </company>
   paid about $1.8 billion in 2008 to purchase LifeCell in order to gain access to AlloDerm and to expand its reach in the tissue repair market.
  </p>
 <MadCap:snippetBlock src="../Resources/Snippets/Master/Editorial/XML text end.flsnp" /></body>
</html>
